Aptamer Group Plc is a biotechnology company. The firm is engaged in the provision of aptamer selection and development services and the development of aptamer-based reagents. The company was founded by Arron Tolley and David Bunka in 2008 and is headquartered in York, the United Kingdom.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company